Re-interpretation of PAM50 gene expression as quantitative tumor dimensions shows utility for clinical trials: application to prognosis and response to paclitaxel in breast cancer

  1. Camp, N.J.
  2. Madsen, M.J.
  3. Herranz, J.
  4. Rodríguez-Lescure, Á.
  5. Ruiz, A.
  6. Martín, M.
  7. Bernard, P.S.
Revue:
Breast Cancer Research and Treatment

ISSN: 1573-7217 0167-6806

Année de publication: 2019

Volumen: 175

Número: 1

Pages: 129-139

Type: Article

DOI: 10.1007/S10549-018-05097-5 GOOGLE SCHOLAR lock_openAccès ouvert editor